Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 6/2020

01-12-2020 | Endocarditis | Correspondence

Reply to the correspondence “Staphylococcus capitis causing infective endocarditis: not so uncommon” by Tchana-Sato & Defraigne

Author: Ziad A. Memish

Published in: Infection | Issue 6/2020

Login to get access

Excerpt

To the Editor, …
Literature
1.
2.
Al Hennawi HET, Mahdi EM, Memish ZA. Native valve Staphylococcus capitis infective endocarditis: a mini review. Infection. 2020;48(1):3–5.CrossRef
Metadata
Title
Reply to the correspondence “Staphylococcus capitis causing infective endocarditis: not so uncommon” by Tchana-Sato & Defraigne
Author
Ziad A. Memish
Publication date
01-12-2020
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 6/2020
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-020-01501-9

Other articles of this Issue 6/2020

Infection 6/2020 Go to the issue

Original Paper

Cardiac manifestations of COVID-19 in Shenzhen, China

Original Paper

Intrinsic resistance to terbinafine among human and animal isolates of Trichophyton mentagrophytes related to amino acid substitution in the squalene epoxidase

Review

The epidemiological burden and overall distribution of chronic comorbidities in coronavirus disease-2019 among 202,005 infected patients: evidence from a systematic review and meta-analysis

Case Report

Utility of CT scan in patients with initial negative PCR for SARS-CoV2: a report of three cases

Original Paper

Renal profile of chronic hepatitis C patients with sofosbuvir-based therapy

Brief Report

Confronting hidden COVID-19 burden: a telemedical solution for elective urological outpatient clinics
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits